Loading
Neurogram™
Neurogram™ is a Brazilian B2B medtech startup founded in 2021, specializing in AI-driven analysis of EEG (electroencephalogram) data. The platform detects neuro-biomarkers for neurological diseases such as epilepsy and Alzheimer's, significantly improving diagnostic accuracy from 70% to 97% while reducing evaluation time and costs. Founded in São Paulo by neuroscientist Daniele de Mari and neurophysiologist Heitor Ettori, Neurogram aims to enhance healthcare efficiency in critical care settings. The core platform automates the storage, management, and analysis of EEG exams, providing one-click instant reports. It is designed to support real-time monitoring and is accessible from anywhere, ensuring secure and efficient data handling. Neurogram has raised $1.02M in Seed VC and additional funding to expand its platform and team. The company is focused on future developments, including integrating EEG with wearables and genomics, and establishing clinical partnerships. Notably, it serves prominent healthcare providers, including Brazil’s largest brain research center, Instituto Estadual do Cérebro Paulo Niemeyer.
Funding
Every round, secondary, debt facility or acquisition involving Neurogram™ that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—